Clinical Trial Update: A Pilot Study of "OncozeneTM" Microspheres for Intra-arterial Delivery of Doxorubicin [Phase 2]

View source ↗

Summary

Phase 2 pilot trial evaluating Oncozene microspheres for intra-arterial doxorubicin delivery in hepatocellular cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• Oncozene

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Hepatocellular Cancer | Phase 2 | Status: COMPLETED